—
C+
C+ The full Closelook — membership. Open the C+ overview

Oxford Nanopore Technologies Ltd (ONT.L) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — Oxford Nanopore Technologies Ltd

ONT.L in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Oxford Nanopore builds sequencing devices that read the order of bases in a strand of DNA or RNA as it passes through a nanoscale pore. Its range runs from the pocket-sized MinION to the benchtop GridION and the higher-throughput PromethION systems, sold with matching software and chemistry kits. It also works with Cepheid on automated sequencing for infectious-disease testing. The company is based in Oxford, England, and sells across the Americas, Europe, the Middle East, Africa, India and Asia-Pacific.
Where it sits in the stack
Oxford Nanopore does not sit in our index yet; it belongs to the life-sciences tools sleeve of our universe, the group that supplies instruments and consumables to genomics and diagnostics labs rather than to the AI compute build-out.
Who it is priced against
No peer group is set for it in our universe yet; the comparison the market draws is with Illumina, the larger incumbent in DNA sequencing.
Why Closelook tracks it
It carries no index seat and no Closelook score in the diary at present; the only entry recorded is a chart reading showing the shares above both their 50-day and 200-day levels while still below their 52-week high.
What the diary watches
Whether instrument placements convert into recurring flow-cell and reagent sales, since that mix, not the device count, decides whether revenue compounds.

Oxford Nanopore Technologies Ltd (ONT.L) trades on the LSE exchange in UK.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for ONT.L, from the same nightly bakes the boards use. Research diary readings, not advice.

Who it is priced against Biotechnology · 8 names with week and year-to-date

Peer group

Biotechnology

This name carries no Closelook score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against ONT.L on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 50/100 · S&P 500 fund at 49, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-18
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 97th percentile of the window, +4.9% over 20 sessions. Factor regime → 2026-09-18
  • Sovereign pressure Index 0.07 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-18

FAQ · from the current data · as of 2026-09-19

Quick answers

What is Oxford Nanopore Technologies Ltd (ONT.L)?

Oxford Nanopore Technologies Ltd trades as ONT.L on the LSE exchange (UK) in the Closelook research universe, as of the registry build of 2026-09-19.

Is ONT.L in a Closelook index?

Not currently — Oxford Nanopore Technologies Ltd is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-19.

Where does ONT.L trade against its moving averages?

Uptrend stack intact: Trades +26.3% vs the 50-day and +33.5% vs the 200-day average, 8.9% below the 52-week high and +82.4% off the 52-week low; a golden cross printed 12 sessions ago. Computed from daily closes. As of 2026-09-18 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does Oxford Nanopore Technologies Ltd do?

Oxford Nanopore builds sequencing devices that read the order of bases in a strand of DNA or RNA as it passes through a nanoscale pore. Its range runs from the pocket-sized MinION to the benchtop GridION and the higher-throughput PromethION systems, sold with matching software and chemistry kits. It also works with Cepheid on automated sequencing for infectious-disease testing. No peer group is set for it in our universe yet; the comparison the market draws is with Illumina, the larger incumbent in DNA sequencing.

Where does Oxford Nanopore Technologies Ltd sit in the AI build-out?

Oxford Nanopore does not sit in our index yet; it belongs to the life-sciences tools sleeve of our universe, the group that supplies instruments and consumables to genomics and diagnostics labs rather than to the AI compute build-out. It carries no index seat and no Closelook score in the diary at present; the only entry recorded is a chart reading showing the shares above both their 50-day and 200-day levels while still below their 52-week high.

What does this page show?

A live price chart with SMA overlays and drawing tools for ONT.L, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe

then Biotechnology. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.